Increasing access to accurate, validated diagnostics in the private sector is key to reducing India’s high tuberculosis burden. CHAI facilitated a partnership between private sector laboratories and manufacturers to support adoption of a low-price, high-volume model that improves access to quality diagnostics and strengthens linkages in India’s healthcare system. Learn more by reading the case study here.
